Brind.

Jim Cramer labeled Insmed as a very speculative investment on July 15, 2025.

1 report, 1 independent Updated Jul 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Jim Cramer labeled Insmed as a very speculative investment on July 15, 2025.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Insider MonkeyJim Cramer Calls Insmed “Very Speculative” Insmed Incorporated (NASDAQ:INSM) is one of the stocks on Jim Cramer’s radar. A caller noted that Cramer has not been quick to recommend biotech companies i